tradingkey.logo

Allurion Reports 23% Weight Loss, 14% Lean Mass Gain On Combining Program With Tirzepatide

ReutersNov 25, 2025 4:44 PM

- Allurion Technologies Inc ALUR.N:

  • ALLURION ANNOUNCES INITIAL RESULTS ON COMBINING THE ALLURION PROGRAM WITH LOW-DOSE TIRZEPATIDE TO OPTIMIZE MUSCLE MASS AND GLP-1 ADHERENCE

  • ALLURION TECHNOLOGIES INC - AVERAGE WEIGHT LOSS OF 23% WITH 14% INCREASE IN LEAN BODY MASS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI